187 related articles for article (PubMed ID: 26221287)
1. Expression of CXCR4 and non-small cell lung cancer prognosis: a meta-analysis.
Liu K; Bao C; Yao N; Miao C; Varlotto J; Sun Q; Sun X
Int J Clin Exp Med; 2015; 8(5):7435-45. PubMed ID: 26221287
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.
Ye Z; Zhang X; Luo Y; Li S; Huang L; Li Z; Li P; Chen G
PLoS One; 2016; 11(9):e0163162. PubMed ID: 27657690
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
Zhang C; Li J; Han Y; Jiang J
Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700
[TBL] [Abstract][Full Text] [Related]
4. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
Xu TP; Shen H; Liu LX; Shu YQ
Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of CXCR4 and correlation with clinicopathological features and prognosis of non-small cell lung cancer patients: a meta-analysis.
Wang H; Xie F; Hu Z; Chen L
Genet Mol Res; 2015 Dec; 14(4):17893-903. PubMed ID: 26782435
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis.
Wu J; Wu X; Liang W; Chen C; Zheng L; An H
Tumour Biol; 2014 Apr; 35(4):3709-15. PubMed ID: 24326770
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.
Qiu L; Xu Y; Xu H; Yu B
BMC Cancer; 2022 Jun; 22(1):681. PubMed ID: 35729596
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance and prognostic role of chemokine receptor CXCR4 expression in pancreatic ductal adenocarcinoma, a meta-analysis and literature review.
Ding Y; Du Y
Int J Surg; 2019 May; 65():32-38. PubMed ID: 30902754
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of CXCR4 in non-small cell lung cancer.
Zhou XM; He L; Hou G; Jiang B; Wang YH; Zhao L
Drug Des Devel Ther; 2015; 9():1349-58. PubMed ID: 25834393
[TBL] [Abstract][Full Text] [Related]
10. Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis.
Zhang Z; Ni C; Chen W; Wu P; Wang Z; Yin J; Huang J; Qiu F
BMC Cancer; 2014 Jan; 14():49. PubMed ID: 24475985
[TBL] [Abstract][Full Text] [Related]
11. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.
Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T
Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Plasma Fibrinogen in Lung Cancer Patients: A Meta-Analysis.
Zhong H; Qian Y; Fang S; Wang Y; Tang Y; Gu W
J Cancer; 2018; 9(21):3904-3911. PubMed ID: 30410594
[No Abstract] [Full Text] [Related]
14. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
15. Predictive role of the overexpression for CXCR4, C-Met, and VEGF-C among breast cancer patients: A meta-analysis.
Wang F; Li S; Zhao Y; Yang K; Chen M; Niu H; Yang J; Luo Y; Tang W; Sheng M
Breast; 2016 Aug; 28():45-53. PubMed ID: 27214240
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of CXCR4 expression in osteosarcoma: a meta-analysis.
Kusuma IGNAW; Yapson GYA; Nolan J; Wiratnaya IGE; Supadmanaba IGP
Biomedicine (Taipei); 2022; 12(4):34-43. PubMed ID: 36816176
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor CXCR4 expression and lung cancer prognosis: a meta-analysis.
Liang JX; Gao W; Liang Y; Zhou XM
Int J Clin Exp Med; 2015; 8(4):5163-74. PubMed ID: 26131090
[TBL] [Abstract][Full Text] [Related]
19. Skip metastasis in mediastinal lymph node is a favorable prognostic factor in N2 lung cancer patients: a meta-analysis.
Wang Z; Cheng J; Huang W; Cheng D; Liu Y; Pu Q; Reticker-Flynn NE; Liu L
Ann Transl Med; 2021 Feb; 9(3):218. PubMed ID: 33708845
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
